Product image of Mibi (Technetium (99mtc) Sestamibi) supplied by GNH India

Mibi

Active Ingredient:
Technetium (99mtc) Sestamibi
Origin:
EU

Mibi (Technetium (99mtc) Sestamibi)

Technetium (99mTc) sestamibi, the active ingredient in Mibi, is a radiopharmaceutical presented as an injection for intravenous use. It is employed to evaluate myocardial blood flow and detect coronary artery disease in patients undergoing cardiac assessment, including stress testing and viability studies.

GNH India supplies Mibi as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, diagnostic centres and cardiac imaging facilities worldwide. The product meets EU regulatory standards and is distributed under strict quality‑control procedures.

Manufacturer / TM Owner

Radiopharmacy Laboratórium Kft.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Mibi is used in cardiac imaging to assess myocardial perfusion and related conditions.

  • Myocardial perfusion imaging: enables visualization of blood flow to detect coronary artery disease.
  • Stress testing: assesses myocardial blood flow response during pharmacologic or exercise stress.
  • Viability assessment: helps differentiate viable myocardium from scar tissue after infarction.

How It Works

  • Technetium‑99m sestamibi is a lipophilic cation that passively diffuses into myocardial cells in proportion to regional blood flow. Once inside the cells, it binds to mitochondrial membranes and becomes trapped, producing a distribution that reflects perfusion and allowing gamma‑camera imaging to generate tomographic maps of myocardial blood flow during rest or stress conditions.

Side Effects

Adverse reactions to Mibi are generally related to the radiopharmaceutical nature of the product and its intravenous administration.

Common Side Effects

  • Nausea: mild to moderate discomfort shortly after injection.
  • Vomiting: occasional emesis within the first hour.
  • Headache: transient headache reported by some patients.
  • Dizziness or light‑headedness: brief sensations of imbalance.
  • Flushing or warmth: mild skin sensation at the injection site.
  • Transient hypotension: temporary drop in blood pressure.

Serious or Rare Side Effects

  • Allergic reaction: rash, urticaria, or anaphylaxis.
  • Severe hypotension: marked blood pressure decline requiring intervention.
  • Cardiac arrhythmia: abnormal heart rhythm observed during stress testing.
  • Radiation‑induced skin injury: localized erythema at the injection site.
  • Radiation‑related malignancy: theoretical risk of long‑term cancer development.
  • Pulmonary embolism: rare occurrence of embolic events.

Precautions & Warnings

When using Mibi, several precautions should be observed to ensure patient safety and optimal imaging results.

  • Patient assessment: evaluate renal function and cardiac status before administration.
  • Pregnancy: avoid use unless essential, as fetal radiation exposure is unknown.
  • Breastfeeding: discontinue breastfeeding for an appropriate period after injection.
  • Concomitant drugs: consider effects of agents that alter myocardial blood flow, such as beta‑blockers or nitrates.
  • Radiation safety: limit exposure to staff and other patients by following shielding protocols.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Avoid Interactions

Mibi may interact with other medications or substances that influence myocardial blood flow or radiation exposure.

Major Interactions (Avoid)

  • Beta‑blockers: can blunt stress‑induced perfusion changes, affecting image interpretation.
  • Calcium channel blockers: may alter coronary vasodilation and tracer distribution.
  • Nitrates: can modify myocardial blood flow, leading to inaccurate perfusion assessment.
  • Dipyridamole: concurrent use interferes with pharmacologic stress protocols.
  • Other radiopharmaceuticals: simultaneous administration can cause competitive uptake.

Moderate Interactions (Monitor Closely)

  • Caffeine: may reduce vasodilator response during stress testing.
  • Nicotine or tobacco use: can affect coronary tone and tracer uptake.
  • Thyroid hormones: altered metabolism may influence tracer clearance.
  • Antihistamines: may mask mild allergic reactions.
  • Contrast agents: timing should be spaced to avoid imaging interference.

Frequently Asked Questions

Mibi is a radiopharmaceutical used primarily for myocardial perfusion imaging. It helps clinicians visualise blood flow to the heart muscle during rest and stress conditions, aiding the diagnosis of coronary artery disease, assessment of cardiac function, and evaluation of myocardial viability.

Technetium‑99m sestamibi is a lipophilic cation that distributes in proportion to regional myocardial blood flow. After intravenous injection it enters heart cells and binds to mitochondrial membranes, becoming trapped. The resulting pattern of radioactivity is captured by a gamma camera, producing images that reflect perfusion of the myocardium.

The administered activity of Mibi is determined by the prescribing physician based on the specific imaging protocol, patient weight, and the equipment used. Dosing follows established nuclear‑medicine guidelines and is tailored to achieve optimal image quality while adhering to radiation‑safety principles.

The safety of Mibi in pregnancy and lactation has not been established. Because it involves ionising radiation, it should be avoided in pregnant women unless the diagnostic benefit clearly outweighs the potential risk. Breastfeeding mothers should discontinue nursing for a period recommended by the treating physician or radiopharmacy.

To order Mibi, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed) and any required import documentation.

The most common alternative for myocardial perfusion imaging is Thallium‑201 chloride. Compared with Thallium‑201, Technetium‑99m sestamibi (Mibi) offers a higher photon energy, resulting in better image resolution and shorter acquisition times. It also has a lower radiation dose and is compatible with modern gamma cameras, though both agents provide similar diagnostic information.

Mibi must be stored refrigerated at 2‑8 °C. Keep the vial in its original packaging, protect it from light, and avoid freezing or shaking the solution. Before use, allow the product to reach room temperature if required by the imaging protocol, and handle it using standard radiation‑safety precautions.

Mibi is administered as a single intravenous injection. The dose is prepared in a sterile vial and injected into a peripheral vein under aseptic conditions. Imaging is performed shortly after injection, typically within minutes for stress studies or after a brief waiting period for rest images, following the specific protocol of the nuclear‑medicine department.

Serious risks include allergic reactions that can progress to anaphylaxis, severe hypotension, and cardiac arrhythmias that may occur during stress testing. Radiation‑related concerns such as skin injury at the injection site or a theoretical long‑term risk of malignancy also exist, although these are rare when standard dosing guidelines are followed.

Mibi should not be used in patients with known hypersensitivity to technetium‑based radiopharmaceuticals, in pregnant women unless absolutely necessary, or in breastfeeding mothers who cannot suspend nursing for the recommended interval. Patients with severe uncontrolled cardiac conditions that preclude stress testing should also be evaluated carefully before administration.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Technetium (99mtc) Sestamibi

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT